Faldaprevir

DB11808InvestigationalSmall molecule

Faldaprevir has been investigated for the treatment of Chronic Hepatitis C.

Chemical structure of Faldaprevir
Formula / weight
C40H49BrN6O9S · 869.821 g/mol (avg)
Code names
BI-201335

Resolves to

Compound
UNII958X4J301ACAS801283-95-4ChEMBLCHEMBL1241348PubChem42601552
Clinical / RWD
ATCJ05AP04PharmGKBPA166128132
Structure
InChIKeyLLGDPTDZOVKFDU-XUHJSTDZSA-NSMILESCOC1=C(Br)C2=C(C=C1)C(O[C@@H]1C[C@H](N(C1)C(=O)[C@@H](NC(=O)OC1CCCC1)C(C)(C)C)C(=O)N[C@@]1(C[C@H]1C=C)C(O)=O)=CC(=N2)C1=CSC(NC(=O)C(C)C)=N1
Targets
P03366gag-pol

What you can answer from here — as of September 13, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
14Drug interactionsStructured to mechanism, not free text
Sign in
16Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1ATC codeIncluding every combination product, plus 19 drug categories
Sign in
1+ReferenceStructured and connected to the statements they support
Sign in

Which drugs share a target with Faldaprevir, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In